Gan Su Min Hai Pharmaceuticals Ltd.
Gan Su Min Hai Pharmaceuticals Ltd., headquartered in Gansu Province, China, is a prominent player in the pharmaceutical industry, specialising in the research, development, and manufacturing of high-quality medicinal products. Founded in 2001, the company has achieved significant milestones, establishing a strong presence in both domestic and international markets. With a focus on traditional Chinese medicine and modern pharmaceutical innovations, Gan Su Min Hai offers a diverse range of products, including herbal remedies and prescription medications. Their commitment to quality and efficacy sets them apart in a competitive landscape. Recognised for their contributions to healthcare, Gan Su Min Hai Pharmaceuticals has garnered a reputation for excellence, positioning itself as a trusted name in the industry. The company continues to expand its operational reach, aiming to enhance global health outcomes through its unique offerings.
DitchCarbon Score
How does Gan Su Min Hai Pharmaceuticals Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Gan Su Min Hai Pharmaceuticals Ltd.'s score of 0 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Gan Su Min Hai Pharmaceuticals Ltd.'s reported carbon emissions
Gan Su Min Hai Pharmaceuticals Ltd. currently does not report any carbon emissions data, as there are no available figures for kg CO2e emissions. Additionally, the company has not established any specific reduction targets or climate pledges. Without emissions data or commitments, it is challenging to assess their climate impact or initiatives. As a result, Gan Su Min Hai Pharmaceuticals Ltd. appears to be in the early stages of addressing climate-related issues within the pharmaceutical industry context.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Gan Su Min Hai Pharmaceuticals Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
